Application Information

This drug has been submitted to the FDA under the reference 017982/001.

Names and composition

"AMIPAQUE" is the commercial name of a drug composed of METRIZAMIDE.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
017982/001 AMIPAQUE METRIZAMIDE INJECTABLE/INJECTION 3.75GM per VIAL
017982/002 AMIPAQUE METRIZAMIDE INJECTABLE/INJECTION 6.75GM per VIAL
017982/003 AMIPAQUE METRIZAMIDE INJECTABLE/INJECTION 2.5GM per VIAL
017982/004 AMIPAQUE METRIZAMIDE INJECTABLE/INJECTION 13.5GM per VIAL

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
017982/001 AMIPAQUE METRIZAMIDE INJECTABLE/INJECTION 3.75GM per VIAL
017982/002 AMIPAQUE METRIZAMIDE INJECTABLE/INJECTION 6.75GM per VIAL
017982/003 AMIPAQUE METRIZAMIDE INJECTABLE/INJECTION 2.5GM per VIAL
017982/004 AMIPAQUE METRIZAMIDE INJECTABLE/INJECTION 13.5GM per VIAL

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved